1646 Metformin 500mg (Sustained Release), Glimepiride 2mg and Pioglitazone 15mg Tablets

1646 Metformin 500mg (Sustained Release), Glimepiride 2mg, and Pioglitazone 15mg Tablets offer comprehensive control for type 2 diabetes. The sustained release formulation of Metformin ensures stable blood sugar levels throughout the day, while Glimepiride and Pioglitazone work synergistically to improve insulin sensitivity and secretion. Ideal for patients needing multi-modal diabetes management.